Human Health Holdings Beheer

Beheer criteriumcontroles 3/4

De CEO Human Health Holdings is Kin Ping Chan, benoemd in Jun2015, heeft een ambtstermijn van 9.42 jaar. De totale jaarlijkse vergoeding van { bedraagt HK$ 4.36M, bestaande uit 57.5% salaris en 42.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.8% van de aandelen van het bedrijf, ter waarde HK$ 5.34M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 9.3 jaar en 9.4 jaar.

Belangrijke informatie

Kin Ping Chan

Algemeen directeur

HK$4.4m

Totale compensatie

Percentage CEO-salaris	57.5%
Dienstverband CEO	9.4yrs
Eigendom CEO	1.8%
Management gemiddelde ambtstermijn	9.3yrs
Gemiddelde ambtstermijn bestuur	9.4yrs

Recente managementupdates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Analyse CEO-vergoeding

Hoe is Kin Ping Chan's beloning veranderd ten opzichte van Human Health Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	HK$4m	HK$3m	HK$24m
Mar 31 2024	n/a	n/a	-HK$22m
Dec 31 2023	n/a	n/a	-HK$67m
Sep 30 2023	n/a	n/a	HK$57m
Jun 30 2023	HK$5m	HK$2m	HK$181m
Mar 31 2023	n/a	n/a	HK$367m
Dec 31 2022	n/a	n/a	HK$553m
Sep 30 2022	n/a	n/a	HK$464m
Jun 30 2022	HK$3m	HK$2m	HK$375m
Mar 31 2022	n/a	n/a	HK$297m
Dec 31 2021	n/a	n/a	HK$218m
Sep 30 2021	n/a	n/a	HK$181m
Jun 30 2021	HK$2m	HK$2m	HK$144m
Mar 31 2021	n/a	n/a	HK$59m
Dec 31 2020	n/a	n/a	-HK$27m
Sep 30 2020	n/a	n/a	-HK$33m
Jun 30 2020	HK$2m	HK$2m	-HK$40m
Mar 31 2020	n/a	n/a	-HK$11m
Dec 31 2019	n/a	n/a	HK$19m
Sep 30 2019	n/a	n/a	HK$23m
Jun 30 2019	HK$2m	HK$2m	HK$27m
Mar 31 2019	n/a	n/a	HK$26m
Dec 31 2018	n/a	n/a	HK$25m
Sep 30 2018	n/a	n/a	HK$24m
Jun 30 2018	HK$2m	HK$2m	HK$24m

Compensatie versus markt: De totale vergoeding ($USD 560.11K ) Kin Ping } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.55K ).

Compensatie versus inkomsten: De vergoeding van Kin Ping is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Kin Ping Chan (60 yo)

9.4yrs

Tenure

HK$4,358,000

Compensatie

Mr. Kin Ping Chan, BBS, J.P, serves as the Chairman of the Board at Human Health Holdings Limited and has been its Chief Executive Officer and Executive Director since June 9, 2015. Mr. Chan is a Co-Owner...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.3m
Chun Pong Poon	COO & Executive Director	11.2yrs	HK$3.96m	0.13% HK$ 379.1k
Lai Sheung Pang	Chief Medical Officer & Executive Director	no data	HK$4.36m	geen gegevens
Tin Wai Chan	Group CFO	1.8yrs	geen gegevens	geen gegevens
Siu Keung Seto	Co-Head of Dental Unit	9.3yrs	geen gegevens	geen gegevens
Wai Man Lau	Co-Head of Dental Unit	9.3yrs	geen gegevens	geen gegevens
Ching Yan Man	Company Secretary	7.4yrs	geen gegevens	geen gegevens

9.3yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1419 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 9.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.3m
Chun Pong Poon	COO & Executive Director	9.4yrs	HK$3.96m	0.13% HK$ 379.1k
Lai Sheung Pang	Chief Medical Officer & Executive Director	9.4yrs	HK$4.36m	geen gegevens
Yue Kwong Chan	Independent Non-Executive Director	8.8yrs	HK$180.00k	geen gegevens
Sun Wing Lui	Independent Non-Executive Director	8.8yrs	HK$180.00k	geen gegevens
Kar Tim Sin	Independent Non-Executive Director	8.8yrs	HK$180.00k	geen gegevens
Kin Hung Kwong	Member of Doctor Advisory Board	15.3yrs	geen gegevens	geen gegevens
Huen Lee	Member of Doctor Advisory Board	12.1yrs	geen gegevens	geen gegevens
Hey Man Chan	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

9.4yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1419 wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.4 jaar).

Human Health Holdings Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd